Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CFRX ContraFect > Detailed Quotes

CFRX ContraFect

Watchlist
0.070
-0.001-1.41%
Close  02/02 16:00 ET
0.080
+0.010+14.53%
Pre Mkt Price 02/03 04:29 ET
High
0.073
Open
0.068
Turnover
913.09K
Low
0.067
Pre Close
0.071
Volume
13.15M
Market Cap
3.04M
P/E(TTM)
Loss
52wk High
4.540
Shares
43.68M
P/E(Static)
Loss
52wk Low
0.059
Float Cap
2.55M
Bid/Ask %
-66.67%
Historical High
62.400
Shs Float
36.67M
Volume Ratio
0.30
Historical Low
0.059
Dividend TTM
--
Div Yield TTM
--
P/B
-0.98
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
35.86%
Amplitude
8.59%
Avg Price
0.069
Lot Size
1
Float Cap
2.55M
Bid/Ask %
-66.67%
Historical High
62.400
Shs Float
36.67M
Volume Ratio
0.30
Historical Low
0.059
Dividend TTM
--
P/B
-0.98
Dividend LFY
--
Turnover Ratio
35.86%
Amplitude
8.59%
Avg Price
0.069
Lot Size
1
Price Forecast

News

Comment

Company Overview More
ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.
CEO: Dr. Roger J. Pomerantz, F.A.C.P.,M.D.
Market: NASDAQ
Listing Date: 07/29/2014
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist